Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

46.70p
   
  • Change Today:
      0.65p
  • 52 Week High: 47.70
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 1,114,944
  • Market Cap: £252.44m
  • RiskGrade: 119
  • Beta: 1.11

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.

1 Day Chart (14-11-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -21.3% 20.9%
ROCE n/a  
Latest F'cast
P/E 10.3 10.6
PEG 1.6 n/a
Pr/Revenue 1.4 1.3
Pr/Book 1.2  
Latest F'cast
Revenue 7.9% 5.2%
PBT n/a n/a
EPS 6.3% -3.5%
DPS n/a n/a

Alliance Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%
31-Dec-22 167.42 (23.05) 4.28p 12.4 n/a -33% 1.78p 3.4%
31-Dec-23 180.68 (48.80) 4.55p 8.9 1.5 +6% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 190.02 39.64 4.39p 10.6 n/a -4% n/a 0.0%
31-Dec-25 201.48 41.25 5.01p 9.3 0.7 +14% n/a 0.0%
31-Dec-26 212.77 43.83 5.67p 8.2 0.6 +13% n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Notification of Major Holdings 10-Oct-2024 18:11 RNS
Interim Results 30-Sep-2024 07:00 RNS
Notification of Half Year Results 12-Sep-2024 07:00 RNS

Alliance Pharma ShareCast News

Revenue, profits rise for Alliance Pharma 30-Sep-2024 ShareCast
Alliance Pharma flags solid rise in first-half r... 29-Jul-2024 ShareCast
Alliance Pharma COO stepping down, position to b... 23-Jul-2024 ShareCast

Alliance Pharma Top Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 46.70p
Change Today 0.65p
% Change 1.41 %
52 Week High 47.70
52 Week Low 29.35
Volume 1,114,944
Shares Issued 540.57m
Market Cap £252.44m
Beta 1.11
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.78% below the market average14.78% below the market average14.78% below the market average14.78% below the market average14.78% below the market average
36.00% above the sector average36.00% above the sector average36.00% above the sector average36.00% above the sector average36.00% above the sector average
Price Trend
56.97% above the market average56.97% above the market average56.97% above the market average56.97% above the market average56.97% above the market average
76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average
Income Not Available
Growth
39.91% below the market average39.91% below the market average39.91% below the market average39.91% below the market average39.91% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 14-Nov-2024

Time Volume / Share Price
16:35 645 @ 46.70p
16:35 17,340 @ 46.70p
16:35 102 @ 46.70p
16:35 638 @ 46.70p
16:35 112 @ 46.70p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page